TY - JOUR
T1 - Conformation and interactions of bombolitin I analogues with SDS micelles and phospholipid vesicles
T2 - CD, fluorescence, two‐dimensional NMR and computer simulations
AU - Chorev, Michael
AU - Gurrath, Marion
AU - Behar, Vered
AU - Mammi, Stefano
AU - Tonello, Antonella
AU - Peggion, Evaristo
PY - 1995/10
Y1 - 1995/10
N2 - Bombolitins are five structurally related heptadecapeptides acting at the membrane level able to lyse erythrocytes and liposomes and to enhance the activity of phospholipase A 2(PLA2). In the presence of SDS or phospholipid vesicles bombolitins are able to form amphiphilic α‐helical structures and this property seems to be the major determinant of bioactivity. In order to test the model of interaction between bombolitin I and membranes, an analogue was synthesized in which all the lysines were replaced by arginines: (Formula Presented.) ([Arg2,9,12, Ile10] bornbolitin I). The design ofthis sequence allowed the synthesis of a second analogue through a specijic postsynthetic dansylation at the ϵ‐amino group qf a lysine residue replacing the original leucine residue at position 7. The, first analogue was, fiilly characterized by CD and two‐dimensional nmr in the presence of SDS or phospholipid vesicles. The peptide, folds into an amphiphilic α‐helical confbrrnation with the helical segment spanning the central part of the sequencefrom Ile3 to His16. This behavior is identical to that observed for the native sequence. The replacement of Iysine residues by arginine hus no detectable effect on the conformational prderence of the peptide chain. By CD and fluorescence spectroscopy measurements, the fluorophore‐containing analogue [Arg2,9,12, Lys7(ϵ‐dansyl)] bombolitin I also folded into the α‐helical conformation in the presence of SDS micelles or phospholipid vesicles. In particular, the dansyl fluorophore, which is located approximately in the middle of the apolar surface ojthe amphiphilic helix, is clearly buried in a hydrophobic environment when the peptide is bound to phospholipid vesicles. These findings support the hypothesis that the peptide helices are oriented parallel to the vesicle surface. © 1995 John Wiley & Sons, Inc.
AB - Bombolitins are five structurally related heptadecapeptides acting at the membrane level able to lyse erythrocytes and liposomes and to enhance the activity of phospholipase A 2(PLA2). In the presence of SDS or phospholipid vesicles bombolitins are able to form amphiphilic α‐helical structures and this property seems to be the major determinant of bioactivity. In order to test the model of interaction between bombolitin I and membranes, an analogue was synthesized in which all the lysines were replaced by arginines: (Formula Presented.) ([Arg2,9,12, Ile10] bornbolitin I). The design ofthis sequence allowed the synthesis of a second analogue through a specijic postsynthetic dansylation at the ϵ‐amino group qf a lysine residue replacing the original leucine residue at position 7. The, first analogue was, fiilly characterized by CD and two‐dimensional nmr in the presence of SDS or phospholipid vesicles. The peptide, folds into an amphiphilic α‐helical confbrrnation with the helical segment spanning the central part of the sequencefrom Ile3 to His16. This behavior is identical to that observed for the native sequence. The replacement of Iysine residues by arginine hus no detectable effect on the conformational prderence of the peptide chain. By CD and fluorescence spectroscopy measurements, the fluorophore‐containing analogue [Arg2,9,12, Lys7(ϵ‐dansyl)] bombolitin I also folded into the α‐helical conformation in the presence of SDS micelles or phospholipid vesicles. In particular, the dansyl fluorophore, which is located approximately in the middle of the apolar surface ojthe amphiphilic helix, is clearly buried in a hydrophobic environment when the peptide is bound to phospholipid vesicles. These findings support the hypothesis that the peptide helices are oriented parallel to the vesicle surface. © 1995 John Wiley & Sons, Inc.
UR - https://www.scopus.com/pages/publications/0029150381
U2 - 10.1002/bip.360360410
DO - 10.1002/bip.360360410
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 7578942
AN - SCOPUS:0029150381
SN - 0006-3525
VL - 36
SP - 473
EP - 484
JO - Biopolymers
JF - Biopolymers
IS - 4
ER -